Definition

White Space Analysis

White space analysis is a market research method that finds segments, geographies or customer groups where demand exists but current products, services or providers do not meet it, marking them as openings for growth.

2 min readReviewed September 14, 2026

Also known as: Whitespace analysis, White space opportunity, Market gap analysis

What is white space analysis?

White space analysis maps what a market needs against what is already offered, then looks for the uncovered areas. The term comes from strategy work, where a grid of customer segments and offerings is filled in and the blank cells show where no one competes or where one company has no presence.

In healthcare the gaps can be geographic, such as counties with many patients but few specialists, or competitive, such as a drug with few manufacturers. For a company already in a market, white space often means existing accounts that buy one product line but not another.

Types of white space in healthcare

Most healthcare white space analyses fall into a few patterns:

  • Geographic: areas where population, disease burden or procedure demand outpaces the local supply of providers, facilities or pharmacies.
  • Service line: services a health system does not offer locally, or services residents currently travel elsewhere to receive.
  • Competitive: drugs or devices with few suppliers, such as products with only one or two approved generic manufacturers.
  • Account: existing customers who buy some products but not others, the classic cross-sell gap in a sales territory.

Why white space analysis matters

Medical device and pharmaceutical teams use it to prioritize territories and decide where to add field staff. Health systems and private equity investors use it to choose sites for new clinics, ambulatory surgery centers or practice acquisitions. Generic drug makers use competitive white space to pick development targets.

Public data supports the supply side of the analysis. Provider counts by specialty and location come from the National Plan and Provider Enumeration System (NPPES), shortage designations come from Health Professional Shortage Area (HPSA) files published by the Health Resources and Services Administration (HRSA), and competitor counts for drugs come from FDA sources such as the Orange Book.

Limitations of white space analysis

A blank cell is not proof of an opportunity. Some gaps exist because demand is too small, reimbursement is too low, or state certificate of need laws restrict new facilities and services.

Supply data can also mislead. A provider's listed address may be a billing office rather than where care is delivered, and one physician may practice at several sites, so provider counts by ZIP code should be checked against utilization data before a gap is treated as real.

Sources

All glossary terms